SCHEMBL14824789

SCHEMBL14824789

CC(C)(O)C(C)(C)OBc1ccc(N)c(F)c1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23693409 0.80 — —
SCHEMBL19299765 0.78 — —
SCHEMBL24773785 0.77 — —
SCHEMBL18059180 0.77 CYP3A4 (0.37) —
SCHEMBL23201472 0.75 — —
SCHEMBL23693410 0.74 — —
SCHEMBL25011790 0.74 IDO1 (0.39) —
SCHEMBL22924380 0.74 PDE2A (0.30) —
SCHEMBL23638849 0.74 PPARG (0.33) —
SCHEMBL24874118 0.73 MEN1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2757096-A9 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-11-26 — — EP disclosed
EP-2757096-A1 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-07-23 — — EP disclosed
EP-2220084-B1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION GILEAD SCIENCES INC (US) 2014-02-19 — — EP disclosed
EP-2574610-A1 Inhibitors of human immonodeficiency virus replication GILEAD SCIENCES, INC. (US) 2013-04-03 — — EP disclosed
Send feedback